Skip to main content
. 2012 Mar 1;302(10):G1171–G1179. doi: 10.1152/ajpgi.00352.2011

Fig. 4.

Fig. 4.

Genetic deficiency of CD39 accelerates hemorrhage and increases mortality in APAP hepatotoxicity. WT (n = 6) and CD39−/− mice (n = 6) were administered APAP at 200 mg/kg ip. Liver histology was assessed at 12 h post-APAP treatment (A and B). Survival was assessed to 72 h in WT (n = 8) and CD39−/− mice (n = 8) administered APAP at 500 mg/kg ip (C). *P < 0.05.